{
    "accession": "ENCBS521QMI",
    "age": "53",
    "age_units": "year",
    "applied_modifications": [
        {
            "category": "insertion",
            "introduced_tags": [
                {
                    "location": "C-terminal",
                    "name": "eGFP"
                }
            ],
            "method": "CRISPR",
            "modified_site_by_target_id": "MYC",
            "purpose": "tagging"
        }
    ],
    "biosample_term_id": "EFO:0002067",
    "biosample_term_name": "K562",
    "biosample_type": "cell line",
    "characterizations": [],
    "dbxrefs": [],
    "description": "",
    "documents": [
        {
            "attachment": "/documents/716003cd-3ce7-41ce-b1e3-6f203b6632a0/@@download/attachment/ENCODE4%20_Snyder_ChIP-seq_BiorupterTruSeqProtocol_v1.pdf",
            "document_type": "general protocol",
            "references": [],
            "urls": []
        }
    ],
    "donor": "ENCDO000AAD",
    "health_status": "chronic myelogenous leukemia (CML)",
    "lab": "Michael Snyder, Stanford",
    "life_stage": "adult",
    "organism": "Homo sapiens",
    "references": [],
    "sex": "female",
    "source": "ATCC",
    "summary": "Homo sapiens K562 cell line genetically modified (insertion) using CRISPR targeting MYC",
    "treatments": []
}